99 results on '"Ost, P."'
Search Results
2. Imaging targeted treatments versus extended salvage lymph node dissection for patients with a single nodal recurrence of prostate cancer: A comparative analysis from a large multi-institutional series
3. Assessing the impact and predictors of other-cause mortality in patients treated with post-prostatectomy salvage radiation therapy in order to avoid possible overtreatment: Results from a large, multi-institutional study
4. There is no way to compensate for a non-timely use of salvage radiation therapy in men with recurrent prostate cancer after radical prostatectomy
5. Assessing the impact and predictors of other-cause mortality in patients treated with post-prostatectomy salvage radiation therapy in order to avoid possible overtreatment: Results from a large, multi-institutional study
6. Randomized phase 1 trial of pembrolizumab with neo-adjuvant versus concomitant stereotactic body radiotherapy in metastatic urothelial carcinoma: Clinical and translational results
7. Imaging targeted treatments versus extended salvage lymph node dissection for patients with a single nodal recurrence of prostate cancer: A comparative analysis from a large multi-institutional series
8. What is the best definition of biochemical response to salvage radiation therapy in prostate cancer patients treated for PSA rising after radical prostatectomy? Results from a multi-institutional series
9. Comparing stereotactic body radiotherapy and elective nodal radiotherapy in the management of nodal oligorecurrent prostate cancer: A multi-institutional analysis
10. Castration-resistant prostate cancer-free survival in the multicentric prospective local treatment of metastatic prostate cancer (LoMP) trial
11. There is no way to compensate for a non-timely use of salvage radiation therapy in men with recurrent prostate cancer after radical prostatectomy
12. Metastasis-directed therapy for oligoprogressive castration refractory prostate cancer
13. Comparing stereotactic body radiotherapy and elective nodal radiotherapy in the management of nodal oligorecurrent prostate cancer: a multi-institutional analysis
14. Exercise prescription dose for castration resistant prostate cancer patients: A phase I prescription dose escalation trial
15. When should salvage radiation therapy be associated with concomitant hormonal therapy in patients affected by prostate cancer? The key role of PSA doubling time
16. What is the optimal field of post-prostatectomy radiation therapy? Long-term results from a multi-institutional study
17. The prognostic role of early PSA response after salvage radiation therapy: Long-term results from a multi-institutional study
18. Patient versus physician-reported outcomes in hypofractionated radiotherapy for prostate cancer
19. Which patients should be still considered for late salvage radiotherapy for rising or persistently elevated PSA after radical prostatectomy: Results from a large multi-institutional study
20. Is focal therapy for prostate cancer an attractive option? Results of an international survey from the young academic urologists (YAU) amongst 484 physicians
21. Assessing the need for and the optimal duration of hormonal therapy in association with post-prostatectomy radiation therapy: Results from a multi-institutional study
22. Effect of extended pelvic lymph node dissection on oncologic outcomes in D’Amico intermediate- and high-risk radical prostatectomy patients
23. What is the optimal field of post-prostatectomy radiation therapy? Long-term results from a multi-institutional study
24. The prognostic role of early PSA response after salvage radiation therapy: Long-term results from a multi-institutional study
25. How can we expand active surveillance criteria in patients with low- and intermediate risk prostate cancer without increasing the risk of misclassification: Development of a novel risk calculator
26. Adjuvant versus early salvage radiation therapy in node positive prostate cancer patients: A long-term survival analysis
27. Natural history of patients treated with salvage radiation therapy for rising PSA after radical prostatectomy: A long-term survival analysis
28. The occurrence and therapeutic consequences of androgen receptor copy number gain in prostate cancer patients using Droplet Digital PCR
29. More extensive lymph node dissection at radical prostatectomy is associated with improved outcomes after salvage radiotherapy for rising PSA after surgery: A long-term, multi-institutional analysis
30. Assessing the risk of early and late toxicity of post-prostatectomy radiation therapy: A long-term multi-institutional analysis
31. SC189 - Imaging targeted treatments versus extended salvage lymph node dissection for patients with a single nodal recurrence of prostate cancer: A comparative analysis from a large multi-institutional series
32. SC184 - There is no way to compensate for a non-timely use of salvage radiation therapy in men with recurrent prostate cancer after radical prostatectomy
33. SC183 - Assessing the impact and predictors of other-cause mortality in patients treated with post-prostatectomy salvage radiation therapy in order to avoid possible overtreatment: Results from a large, multi-institutional study
34. PT324 - Randomized phase 1 trial of pembrolizumab with neo-adjuvant versus concomitant stereotactic body radiotherapy in metastatic urothelial carcinoma: Clinical and translational results
35. PT278 - Castration-resistant prostate cancer-free survival in the multicentric prospective local treatment of metastatic prostate cancer (LoMP) trial
36. 772 - Imaging targeted treatments versus extended salvage lymph node dissection for patients with a single nodal recurrence of prostate cancer: A comparative analysis from a large multi-institutional series
37. 771 - Comparing stereotactic body radiotherapy and elective nodal radiotherapy in the management of nodal oligorecurrent prostate cancer: A multi-institutional analysis
38. Stereotactic body radiotherapy for nodal oligorecurrent prostate cancer: A multi-institutional analysis
39. Availability of prostate cancer rehabilitation resources and practice patterns: Results of a national survey
40. 680 Whole pelvis intensity-modulated arc therapy for lymph node metastasized prostate cancer: Oncologic outcomes and prognostic factors
41. P064 - Exercise prescription dose for castration resistant prostate cancer patients: A phase I prescription dose escalation trial
42. P046 - Comparing stereotactic body radiotherapy and elective nodal radiotherapy in the management of nodal oligorecurrent prostate cancer: a multi-institutional analysis
43. P249 - The prognostic role of early PSA response after salvage radiation therapy: Long-term results from a multi-institutional study
44. P248 - When should salvage radiation therapy be associated with concomitant hormonal therapy in patients affected by prostate cancer? The key role of PSA doubling time
45. P251 - What is the optimal field of post-prostatectomy radiation therapy? Long-term results from a multi-institutional study
46. 1153 - Patient versus physician-reported outcomes in hypofractionated radiotherapy for prostate cancer
47. 826 - Effect of extended pelvic lymph node dissection on oncologic outcomes in D’Amico intermediate- and high-risk radical prostatectomy patients
48. 539 - Is focal therapy for prostate cancer an attractive option? Results of an international survey from the young academic urologists (YAU) amongst 484 physicians
49. 537 - How can we expand active surveillance criteria in patients with low- and intermediate risk prostate cancer without increasing the risk of misclassification: Development of a novel risk calculator
50. 400 - Assessing the need for and the optimal duration of hormonal therapy in association with post-prostatectomy radiation therapy: Results from a multi-institutional study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.